EGFR and breast cancer: To further investigate the effect of EGFR on BC expression, we treated A549, 95C, 95D and PC9 cells with the EGFR‐selective inhibitor gefitinib and found that BC expression levels in all the cell lines were significantly reduced after the treatment (Figure 2A‐b).